drugset / Trial / NCT05571787
HMPL-523 Food Effect and Proton Pump Inhibitor Study
RandomizedCrossoverOpen-labelOther
Summary
A Phase 1, Open-label, 4-Period, Randomized 6-Sequence Study to Evaluate the Effect of Food and Rabeprazole, a Proton Pump Inhibitor, on the Pharmacokinetics of HMPL-523 in Healthy Volunteers
Timeline
- Start
- 2022-07-13
- Primary completion
- 2022-09-22
- Completion
- 2022-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 40 mg | Oral |
| Subject | Sovleplenib | Small molecule | 700 mg | Oral |